In a video by Lung Foundation Australia, Medical Oncologist Dr. Mal Itchins discusses ROS1-positive lung cancer, a rare subtype of non-small cell lung cancer (NSCLC) driven by a genetic mutation in the ROS1 gene1. This mutation causes the ROS1 gene to fuse with another gene, leading to uncontrolled cell growth.
Dr. Itchins explains that ROS1-positive lung cancer accounts for about 1-2% of all lung cancer cases and often affects younger, non-smoking individuals2. Due to its rarity, there are limited treatment options, and research is crucial for improving patient outcomes.
The video highlights Dr. Itchins’ research, funded by the Lung Foundation Australia, which aims to identify predictive factors for positive treatment responses and improve survival rates for ROS1-positive patients. Her team is also working on establishing a tissue bank to support future research and address challenges like treatment resistance.
Dr. Itchins emphasizes the importance of equitable access to advanced treatments and clinical trials for all patients, regardless of their location or socioeconomic status. She also discusses the emotional and psychological impact of a ROS1-positive lung cancer diagnosis, stressing the need for comprehensive care that includes mental health support.
The video features personal stories from patients, illustrating the real-life impact of ROS1-positive lung cancer and the hope that ongoing research brings1. Dr. Itchins expresses gratitude for the support from the Lung Foundation Australia and the community, which enables her team to continue their vital work. If you or someone you know is affected by lung cancer, reaching out to the Lung Foundation Australia can provide valuable support and information. They are dedicated to helping patients navigate their journey and access the best possible care. For more information and support, individuals can contact the Lung Foundation Australia’s Information and Support Centre at 1800 654 301 or visit their website.
Overall, the video underscores the significance of research and support in improving the lives of those affected by ROS1-positive lung cancer, highlighting the collaborative efforts needed to advance treatment and care.
Was this page helpful?
Good job! Please give your positive feedback
How could we improve this post? Please Help us.